ORILISSA (elagolix sodium)
Abbvie
Patent: 7,056,927
Expiration: Sep 10, 2024
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com